Abbott reports positive VERITAS study results for AFib

​Abbott has reported positive early data from the VERITAS study, evaluating its investigational Amulet 360 LAA occluder, designed to lower stroke risk in patients with non-valvular AFib.

The post Abbott reports positive VERITAS study results for AFib appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

LifeVac receives FDA De Novo classification for anti-choking device
Aisa Pharma reports positive results for AISA-021
BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment
Cognita secures FDA breakthrough device designation for CXR
Seqster unveils 1-Click DataLake for clinical trials

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us